Project Details
Description
The overall objective of thisapplication is to use next generation gene-expression and bioinformatics technology toidentify a molecular signature found in T1 cancers that can differentiate which tumors are likely to 1) respond to intravesical BCG or 2) are resistant to BCG with a high likelihood of progression.
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/17 → 8/31/19 |
Funding
- Hope Foundation (Agmt 8/30/17)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.